Original Research
Accepted on 27 Aug 2025
Efficacy and Safety Analysis of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors with or without Microwave Ablation for Unresectable Hepatocellular Carcinoma: A Retrospective, Multicenter, Case-control Study
in Cancer Immunity and Immunotherapy